The 2018 recipients of the John B. Fenn Award for a Distinguished Contribution in Mass Spectrometry are Gert Von Helden, Martin F. Jarrold, and David E. Clemmer, for their pioneering contributions to the development of ion mobility spectrometry (IMS).
The 2018 recipients of the John B. Fenn Award for a Distinguished Contribution in Mass Spectrometry are Gert Von Helden, Martin F. Jarrold, and David E. Clemmer, for their pioneering contributions to the development of ion mobility spectrometry (IMS). The award lecture for this award will be given Monday at 4:45 pm, in Hall D, at the ground level.
Von Helden is a group leader in the Department of Molecular Physics at the Fritz Haber Institute at the Max Planck Institute for Human Development in Berlin, Germany, and a professor at the Radboud University, in Nijmegen, the Netherlands. Von Helden made a major development in IMS when he applied it to the self-assembly of carbon in plasmas and showed that carbon structurally evolved from linear chains to rings to fullerenes. He used quantum chemical approximation methods to obtain model structures, adapted the little-known projection approximation method to obtain collision cross sections, and obtained excellent agreement with his experimentally measured cross sections.
Jarrold is a professor and the Robert and Marjorie Mann Chair of the Department of Chemistry at Indiana University, in Bloomington, Indiana. Jarrold applied IMS methods to silicon and aluminum assembly, and along with von Helden, showed that fullerenes are formed from activation of carbon ring systems, not C2 addition to graphitic fragments as previously proposed. Jarrold developed the first high-resolution ion mobility instrument and a more accurate method (the trajectory method) for obtaining collision cross-sections from complex structures such as biomolecules.
Clemmer is a distinguished professor in the Department of Chemistry at Indiana University. Clemmer developed a “nested” IMS-MS technology that used ion trapping methods to dramatically increase signal-to-noise ratio and post-IMS dissociation to obtain fragmentation patterns of isomers or conformers in a single experiment. These ideas were later incorporated into successful commercial instruments.
The ASMS Award for Distinguished Contribution in Mass Spectrometry has been renamed to honor the memory of John B. Fenn, who shared the 2002 Nobel Prize for the development of electrospray Ionization. Fenn was an active member of ASMS from 1986 until his passing in 2010.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.